Literature DB >> 11358937

Cardiovascular mortality in hypertensive men according to presence of associated risk factors.

F Thomas1, A Rudnichi, A M Bacri, K Bean, L Guize, A Benetos.   

Abstract

To evaluate the risk of cardiovascular disease (CVD) mortality in hypertensive men according to the presence of associated risk factors (ARFs). The population was composed of 29 640 normotensive men without ARFs (reference group) and 60 343 hypertensive men (with and without ARFs) who had a standard health checkup at the Centre d'Investigations Préventives et Cliniques between 1978 and 1988. Mortality data for a mean period of 14 years were analyzed. The following ARFs were considered: total cholesterol >/=2.5 g/L, personal history of diabetes, smoking (current smokers), body mass index >28 kg/m(2), and heart rate >80 bpm. CVD risk related to the presence of isolated hypertension (assessed in hypertensive subjects without ARFs versus the reference group) increased linearly from 15% at the age of 30 years to 134% at the age of 80 years. In hypertensive subjects, one additional ARF increased CVD risk by 56% (47% to 65%, P<0.01) in younger subjects but only by 4% (-8% to 17%, P=NS) in older subjects. The role of hypercholesterolemia and tobacco smoking in CVD mortality was significantly higher in hypertensive subjects aged <55 years than in hypertensive subjects aged >/=55 years (P<0.01), whereas the roles of tachycardia and obesity were not affected by age. In younger hypertensive subjects, evaluation of CVD risk and therapeutic strategies should target ARFS: In older subjects, the presence of high blood pressure levels seems to be the major determinant of CVD risk.

Entities:  

Mesh:

Year:  2001        PMID: 11358937     DOI: 10.1161/01.hyp.37.5.1256

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom.

Authors:  Thomas M MacDonald; Steven V Morant
Journal:  Br J Clin Pharmacol       Date:  2008-02-14       Impact factor: 4.335

2.  Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Seamus P Whelton; Venkata Narla; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Nancy S Jenny; Mouaz H Al-Mallah; Erin D Michos
Journal:  Am J Cardiol       Date:  2013-11-23       Impact factor: 2.778

3.  Prognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy.

Authors:  Buntaro Fujita; Marcus Franz; Bjoern Goebel; Michael Fritzenwanger; Hans R Figulla; Friedhelm Kuethe; Markus Ferrari; Christian Jung
Journal:  Clin Res Cardiol       Date:  2012-03-28       Impact factor: 5.460

Review 4.  Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications.

Authors:  Guido Grassi; Michele Bombelli; Gianmaria Brambilla; Fosca Quarti Trevano; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 5.  Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy.

Authors:  Paolo Palatini; Athanase Benetos; Stevo Julius
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 6.  Ivabradine: potential clinical applications in critically ill patients.

Authors:  Vincenzo De Santis; Domenico Vitale; Anna Santoro; Aurora Magliocca; Andrea Giuseppe Porto; Cecilia Nencini; Luigi Tritapepe
Journal:  Clin Res Cardiol       Date:  2012-10-14       Impact factor: 5.460

7.  Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patients.

Authors:  Chi Young Shim; Sungha Park; Jung-Sun Kim; Dong Jik Shin; Young-Guk Ko; Seok-Min Kang; Donghoon Choi; Jong-Won Ha; Yangsoo Jang; Namsik Chung
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

8.  Nebivolol/Hydrochlorothiazide : a new fixed-dose combination for effective simplified antihypertensive therapy.

Authors:  Ettore Malacco
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

9.  Grade-response relationship between blood pressure and severity of coronary atherosclerosis in asymptomatic adults: assessment with coronary CT angiography.

Authors:  Tae Seong Im; Eun Ju Chun; Min Su Lee; Theodor Adla; Jeong A Kim; Sang Il Choi
Journal:  Int J Cardiovasc Imaging       Date:  2014-09-02       Impact factor: 2.357

10.  Effects of low-dose combination therapy with an angiotensin-converting enzyme inhibitor and a diuretic on flow-mediated vasodilation in hypertensive patients: a 6-month, single-center study.

Authors:  Cevad Sekuri; Ozgur Bayturan; Hakan Gocer; Talat Tavli; Ugur Kemal Tezcan
Journal:  Curr Ther Res Clin Exp       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.